Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
5-9-2022

Fluoxetine exposure throughout neurodevelopment differentially
influences basilar dendritic morphology in the motor and
prefrontal cortices
Susan E Maloney
Dora R Tabachnick
Christine Jakes
Selma Avdagic
Amy L Bauernfeind

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Authors
Susan E Maloney, Dora R Tabachnick, Christine Jakes, Selma Avdagic, Amy L Bauernfeind, and Joseph D
Dougherty

www.nature.com/scientificreports

OPEN

Fluoxetine exposure
throughout neurodevelopment
differentially influences basilar
dendritic morphology in the motor
and prefrontal cortices
Susan E. Maloney1,2*, Dora R. Tabachnick1,3, Christine Jakes1,3, Selma Avdagic1,3,
Amy L. Bauernfeind4,5 & Joseph D. Dougherty1,2,3
The significance of serotonin (5HT) in mental health is underscored by the serotonergic action of many
classes of psychiatric medication. 5HT is known to have a significant role in neurodevelopment, thus
5HT disruption during development may have a long term impact on brain structure and circuits.
We previously generated a model of 5HT alteration throughout neurodevelopment by maternal
administration of the selective serotonin reuptake inhibitor fluoxetine. We found resulting social
behavior alterations in the offspring during both postnatal and adult ages. Previous work by others
has indicated that early 5HT disruption influences neuronal morphology. Therefore, in the current
study we sought to determine if dendritic morphological changes occur in areas involved in the social
behavior deficits we previously observed, specifically the primary motor (M1) and medial prefrontal
(mPFC) cortices. We quantified dendritic morphology of projection neurons in M1 and mPFC at
postnatal day (P)10 and P79 in mice exposed to fluoxetine. Basilar dendritic complexity and spine
density were persistently decreased in M1 fluoxetine-exposed neurons while in the mPFC, similar
reductions were observed at P79 but were not present at P10. Our findings underscore that the
developing brain, specifically the projection cortex, is vulnerable to 5HT system perturbation, which
may be related to later behavioral disruptions.
Serotonin (5-hydroxytrypamine; 5HT) is one of the most well-studied neurotransmitters influencing mental
health1, and it is a critical target for treatment of psychiatric symptoms2–4. During prenatal neurodevelopment,
5HT is one of the earliest neuromodulators to become active, and 5HT levels and the expression of the 5HT
transporter and 5HT receptors are at their peak, allowing 5HT to modulate critical neurodevelopmental processes
such as neurogenesis, apoptosis, dendritic refinement, cell migration, and synaptic p
 lasticity5,6, and ultimately the
construction of important behavioral circuits. 5HT also regulates the development of its own system through a
negative feedback m
 echanism7. During this time, the placenta is a transient source of 5HT for the fetal forebrain
until it is innervated by 5HT-producing raphe fi
 bers8. In addition, increased 5HT transfer from the placenta
has been shown to alter raphe innervation of the forebrain9. The neurons of the mature 5HT system innervate
the entire CNS, influencing a variety of functions like social reward, sleep–wake cycle, perception, appetite,
aggression, sexual behavior, sensorimotor activity, pain sensitivity, mood, and learning and m
 emory10–12. Thus,
alterations to either exogenous maternal or endogenous fetal sources of 5HT can impact the development of a
range of behavioral circuits, possibly increasing risk for psychiatric outcomes.
Social behavior responses are disrupted in nearly all psychiatric disorders, particularly neurodevelopmental
disorders (NDDs)13–16. 5HT helps to direct behavioral responses to environmental stimuli, likely through its
influence on n
 europlasticity17. Elevated 5HT activity, such as that induced by selective serotonin reuptake
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inhibitor (SSRI) use during pregnancy, may disrupt required sensitivity needed for proper behavior circuit
development. Indeed, we previously reported altered cortical responses to somatosensory stimulation18, as well
as early and late social behavioral deficits in a mouse model of maternal SSRI exposure during pregnancy and
lactation19. In our model, mouse dams were exposed to fluoxetine (FLX), a common SSRI, through gestation and
into the neonatal period. Thus, the developing brains of the offspring were exposed to a 5HT-activing compound
through placental transfer and then lactation. In the offspring, FLX exposure reduced early social communication
displays of ultrasonic vocalizations (USVs) during early postnatal life and disrupted social hierarchy behaviors
in adulthood19.
Here, we used this model to do a next phase interrogation of the role of 5HT in the perturbation of
developmental neuronal architecture, focusing on the cortical regions associated with the specific social
behavior deficits we previously observed. We examined the basilar dendritic morphology of projection neurons
in brain areas previously shown to be involved in USV and social hierarchy behaviors. Specifically, we found
morphological changes in the basilar dendrites of layer V pyramidal neurons of the primary motor cortex
(M1) at the second week postnatal that persisted into adulthood, as well as in neurons of the medial prefrontal
cortex (mPFC) in adulthood. Our findings suggest that FLX’s influence on basilar dendritic morphology may
underlie the behavioral changes we previously uncovered. Understanding the morphological changes that occur
in the brain due to SSRI exposure could aid our understanding of when the 5HT system is most vulnerable to
perturbation and the developing brain most at risk for later significant behavioral disruptions.

Results

We examined the neuronal morphologies of mice exposed to FLX during brain development through dam
drinking water to identify long-term cellular changes within key cortical regions (Fig. 1a). We hypothesized that
dendritic morphology would be altered in areas of the mouse brain relevant to the social behavior deficits that we
observed in our previous work19. The apical dendrite tracings were often truncated; therefore, only morphological
features of the basilar dendrites were quantified.

Maternal FLX results in comparable pregnancy to VEH exposure. To understand if exposure to the
drug differentially influenced the pregnancies of the dams, we analyzed various outcomes related to pregnancy
and drug exposure. We did not find any differences between the VEH- and FLX-exposed dams in this study in
breeding weight, average daily consumption of drug/vehicle water, number of live births, or gestational duration
(see Table 1). Thus, we conclude that FLX exposure resulted in comparable pregnancies to VEH exposure.
Morphological changes observed in M1 layer V neuron dendrites in the early postnatal brain
following maternal FLX persist into adulthood. To follow up on our previous observation of a robust

decrease in USVs at postnatal day (P)5-P9 in mice exposed to maternal FLX, we examined whether there were
corresponding morphological changes in layer V pyramidal neurons in M1 at a similar age (Fig. 1b). We chose
this area based on previous work that sought to identify the circuitry underlying USVs. The specific portion
of M1 sampled here corresponded to the area which sends projections to the nucleus ambiguus, the motor
nucleus of the hindbrain that innervates the muscles of the soft palate, pharynx, and larynx, which is active
during adult mouse USVs20. We quantified the dendritic morphology of these neurons at P10 (Fig. 1c; Tables 2
and 3). The size of the neuron soma was comparable for FLX- and vehicle (VEH)-exposed neurons (Table 3).
The extent of basilar dendrite branching in neurons from FLX-exposed brains was reduced. Specifically, there
were fewer higher order branches in the FLX-exposed neurons as compared to the VEH-exposed neurons
(Fig. 1d). In parallel, fewer total branching nodes were observed, particularly those that create 2nd, 3rd, and
4th order branching (Fig. 1e), which was reflected fewer 2nd, 3rd, and 4th order branch segments (Fig. 1f). The
differences in overall length of basilar dendrites and dendritic length across branch orders in P10 M1 neurons
were not significant (Table 2; Fig. 1g). Application of the Sholl method to spatially analyze complexity revealed
comparable dendritic intersections with the concentric circles at 10 µm intervals (Fig. 1h). Finally, reduced spine
density was observed across dendritic branch orders of FLX neurons, with robust differences at 2nd, 3rd, 4th
and 5th orders (Fig. 1i).
We also quantified dendritic features of M1 layer V projection neuron in adult P79 mouse brains (Fig. 1b,
2a) to determine if alterations to morphology are transient or persistent. Again, we did not observe differences
in soma size between drug groups (Table 3). We also failed to observe a change to the extent of basilar dendritic
branching (Fig. 2b). However, a non-significant reduction in branching nodes and branch segments were
observed in FLX-exposed neurons (Fig. 2c,d). Similar to that observed in P10 M1 neurons, no differences were
observed for branch length or dendritic intersections (Fig. 2e,f). In adult M1 neurons, we did not observe a
reduction in spine density similar to that observed in P10 neurons (Fig. 2g), yet a significant reduction in overall
number of spines was observed (Fig. 2h).
Taken together, our data on M1 layer V neurons indicate FLX exposure during brain development reduced
complexity of basilar dendritic branching and impacted spine numbers that appears to have at least partially
persisted into adulthood.

Maternal FLX results in decreased dendritic branching complexity and spine density in adult
mice in mPFC layer V pyramidal neurons. In our previous work, we found that our model of maternal

FLX exposure affected social hierarchy norms in adulthood, specifically resulting in an increased display of
social dominance compared to c ontrols19. Previous research also showed that excitatory synaptic efficacy of
layer V pyramidal cells in the mPFC regulated social dominance rank in the mouse21. Therefore, to determine if
perinatal FLX exposure altered features of these neurons at a similar age at which social dominance alterations
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Figure 1.  Maternal FLX reduces the extent of basilar dendritic branching and spine density of M1 layer V
pyramidal neurons at P10. (a) Schematic of the experimental paradigm. (b) M1 area used for neuron selection
marked in grey; adapted from Franklin and Paxinos, 200848. Numbers indicate distance from bregma. (c)
Representative tracings of Golgi-Cox impregnated M1 layer V neurons from P10 FLX and VEH brains. Areas
in black indicate quantified basilar dendrites and soma. Scale bars are 50 µm. (d) FLX neurons did not exhibit
the extent of basilar dendritic branching as VEH control neurons at P10 (n = 10 neurons averaged from 5 FLX
mice and n = 10 neurons averaged from 5 VEH mice). Inset: schematic of dendritic branch orders, where 1st
order branches initiate at the soma, and each subsequent branch order extends from the previous, lower order.
(e) Fewer basilar branching nodes were observed in FLX-exposed neurons compared to VEH-exposed neurons,
with particularly robust deficits at 1st, 2nd, and 3rd branch orders. (f) Number of dendritic segments per branch
order were reduced in FLX neurons at orders 2, 3 and 4. (g) Comparable basilar dendritic length per branch
order was observed between FLX- and VEH-exposed neurons. (h) Number of intersections with concentric
circles per 10 µm distance from the soma as assessed by Sholl analysis did not differ between drug groups. (i)
FLX-exposed neurons showed significantly reduced spine density over all with the greatest differences occurring
at orders 2–5. Data are means ± SEM. Statistical significance, ***p < .001, **p < .01, *p < .05.
VEH (n = 4)

FLX (n = 3)

Mann–Whitney U Test

Pregnancy Outcome

M

SD

M

SD

U statistic

Dam Breeding Weight (g)

24.36

2.48

20.63

3.99

Avg. Daily Drug Water Consumed (g)

7.77

1.58

6.81

Pups in Litter

5.75

0.96

8.00

21.00

1.15

21.67

Gestation Duration (day)

z score

p value

3

−1.061

0.400

0.66

4

−0.707

0.629

1.73

11

1.852

0.114

1.53

8

0.764

0.629

Table 1.  Pregnancy outcomes between FLX- and VEH-exposed dams.
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Figure

Variable

Comparison

Statistical Test

Output

p value

Table 3

P10 M1 soma area

Drug

ANOVA

F(1,8) = .384

0.553

P10 M1 highest branch order

Drug

ANOVA

F(1,8) = 11.066

0.010

Drug

rmANOVA

F(1,8) = 8.210

0.021

F(7,56) = 2.610

0.021

Simple main effect

F(1,64) = 6.279

0.015

Drug x Order
P10 M1 branching nodes

P10 M1 branch segments
1
P10 M1 branch length
P10 M1 Intersections

1st Order, Drug
2nd Order, Drug

Simple main effect

F(1,64) = 13.170

0.0006

3rd Order, Drug

Simple main effect

F(1,64) = 11.356

0.0013

Drug

rmANOVA

F(1,8) = 4.601

0.064

2nd Order, Drug

Simple main effect

F(1,64) = 4.063

0.288‡

3rd Order, Drug

Simple main effect

F(1,64) = 8.389

0.040‡

4th Order, Drug

Simple main effect

F(1,64) = 7.193

0.072‡

Drug

rmANOVA

F(1,8) = 2.570

0.148

3rd Order, Drug

Simple main effect

F(1,64) = 6.970

0.080‡

Drug

rmANOVA

F(1,8) = 2.156

0.180

30 µm, Drug

Simple main effect

F(1,104) = 8.822

0.052‡

F(1,8) = 15.502

0.004

Drug
Drug x Order
P10 M1 spine density

Table 3

2

Table3

P79 M1 soma area

0.034

F(1,64) = 4.135

0.046

3rd Order, Drug

Simple main effect

F(164) = 9.089

0.004

4th Order, Drug

Simple main effect

F(1,64) = 15.182

0.0002

5th Order, Drug

Simple main effect

F(1,64) = 7.540

0.008

Drug

ANOVA

F(1,7) = .032

0.863

P79 M1 highest branch order

Drug

ANOVA

F(1,7) = .018

0.898

Drug

rmANOVA

F(1,7) = 4.666

0.068

P79 M1 branch segments

Drug

rmANOVA

F(1,7) = 4.201

0.080

P79 M1 branch length

Drug

rmANOVA

F(1,7) = 1.605

0.246

P79 M1 Intersections

Drug

rmANOVA

F(1,7) = 2.264

0.176

P79 M1 spine density

Drug

rmANOVA

F(1,7) = .065

0.806

P79 M1 spine numbers

Drug

rmANOVA

F(1,7) = 6.032

0.044

P79 mPFC soma area

Drug

ANOVA

F(1,8) = 3.458

0.100

P79 mPFC branching nodes

Table 3

Simple main effect

F(5.5,44.2) = 2.597

P79 M1 branching nodes

P79 mPFC highest branch order

3

2nd Order, Drug

rmANOVA

P79 mPFC branch segments

Drug

ANOVA

F(1,8) = 14.227

0.005

Drug

rmANOVA

F(1,8) = 4.256

0.073

1st Order, Drug

Simple main effect

F(1,48) = 6.312

0.090‡

Drug

rmANOVA

F(1,8) = 4.997

0.056

2nd Order, Drug

Simple main effect

F(1,48) = 5.072

0.174‡

P79 mPFC branch length

Drug

rmANOVA

F(1,8) = 1.004

0.346

P79 mPFC Intersections

Drug

rmANOVA

F(1,8) = .225

0.648

P79 mPFC spine density

Drug

rmANOVA

F(1,8) = 5.264

0.053

P10 mPFC soma area

Drug

ANOVA

F(1,8) = .2.708

0.138

Drug

ANOVA

P10 mPFC highest branch order

Drug
P10 M1 branching nodes

Drug x Order
1st Order, Drug
Drug

P10 mPFC branch segments
4

Drug x Order

Simple main effect
rmANOVA

1st Order, Drug

Simple main effect

2nd Order, Drug

Simple main effect

Drug
Drug x Distance
P10 mPFC Intersections

rmANOVA

20 µm, Drug

rmANOVA
Simple main effect

F(1,8) = .200

0.760

F(1,8) = .241

0.637

F(8,64) = 2.362

0.027

F(1,72) = 16.187

0.0001

F(1,8) = .658

0.441

F(8,64) = 2.145

0.044

F(1,72) = 4.509

0.037

F(1,72) = 10.601

0.002

F(1,8) = .679

0.434

F(19,152) = 1.968

0.013

F(1,160) = 16.446

0.00008

30 µm, Drug

Simple main effect

F(1,160) = 6.520

0.012

40 µm, Drug

Simple main effect

F(1,160) = 5.537

0.020

P10 mPFC branch length

Drug

rmANOVA

F(1,8) = 1.102

0.324

P10 mPFC spine numbers

Drug

rmANOVA

F(1,8) = .220

0.652

Table 2.  Statistical analysis results from all experiments. ‡ Indicates Bonferroni corrected observed p value.
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P10 VEH
Basilar dendritic parameter (n = 5 M1, n = 5 mPFC)
Soma area (µm2)

M1

P79 FLX
(n = 5 M1, n = 5 mPFC)

207.47 ± 25.09

8.47 ± 1.06*

3.87 ± 1.21*

15.07 ± 1.47

214.21 ± 14

9.93 ± 2.58

454.16 ± 51.13

308.12 ± 75.4

542.87 ± 73.62^

338.43 ± 77.59^

Length (µm)

871.37 ± 123.36

668.18 ± 104.31

1246.25 ± 92.88*

755.53 ± 160.85*

1.12 ± 0.04

1.18 ± 0.08

1.52 ± 0.08

345.4 ± 46.72

337.51 ± 24.72

Endings

3.7 ± 1.37

4.47 ± 0.76

9.8 ± 1.11^

6.83 ± 0.91^

13.27 ± 1.81

18.95 ± 1.85^

14.87 ± 0.59^

350.13 ± 57.57

259.7 ± 77.91

419.93 ± 91.21

0.94 ± 0.08^

1.15 ± 0.07^

Spine density

1.28 ± 0.29
291.14 ± 3.28

10.6 ± 2.16
264.19 ± 58.2

Spines

12.5 ± 1.24

265.44 ± 13.37

Nodes

5 ± 0.42^

16.71 ± 2.35

Length (µm)

Soma area (µm2)

219.15 ± 21.85

7.58 ± 1.25^

Spines
Spine density

mPFC

P79 VEH
(n = 4 M1, n = 5 mPFC)

227.27 ± 19.77

Nodes
Endings

P10 FLX
(n = 5 M1, n = 5 mPFC)

925.71 ± 116.19

750.16 ± 131.17

1322.45 ± 160.1

1016.6 ± 189.23

1.47 ± 0.12

1.37 ± 0.09

Table 3.  Morphometric feature summary of layer V pyramidal neurons. Results are mean ± SEM. *p < .05,
^p < .10.
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Figure 2.  Maternal FLX impact on M1 pyramidal neurons is persistently by decreased by P79. (a)
Representative tracings of Golgi-Cox impregnated mPFC layer V neurons from P79 FLX and VEH brains. Areas
in black indicate quantified basilar dendrites and soma. Scale bar is 50 µm. (b) A comparable extent of basilar
dendritic branching was observed in P79 VEH- and FLX-exposed neurons of the M1 (n = 10 neurons averaged
from 4 VEH mice and n = 10 neurons averaged from 5 FLX mice). (c-d) Number of basilar branching nodes and
dendritic segments per basilar dendritic branch order were non-significantly reduced in FLX-exposed neurons
compared to VEH-exposed neurons at P79. (e–f) Basilar dendritic length per branch order and number of
intersections per 10 µm distance from the soma were unchanged in FLX-exposed neurons at P79. (g) FLXexposure did not influence spine density per basilar dendritic branch order in P79 neurons. (h) Total number
of basilar spines was reduced in FLX-exposed neurons compared to VEH-exposed neurons at P79. Data are
means ± SEM.
were previously observed, we quantified their dendritic morphology at P79 (Fig. 3a,b; Tables 2 and 3). The soma
size of FLX neurons was smaller compared to VEH-exposed, although this difference did not reach statistical
significance (Table 3). We also observed a reduction in the extent of overall basilar dendritic branching in that
the highest branch order of FLX dendrites failed to reach that of VEH dendrites (Fig. 3c). In parallel, a nonsignificant reduction in overall nodes was observed (Fig. 3d), as well as in branch segment numbers (Fig. 3e),
which was particularly robust for 2nd order segments. The overall length of basilar dendrites and dendritic length
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Figure 3.  Maternal FLX results in decreased dendritic branching complexity and spine density in adult mice
in mPFC layer V pyramidal neurons. (a) mPFC area used for neuron selection marked in grey; adapted from
Franklin and Paxinos, 2 00848. Number indicates distance from bregma. (b) Representative tracings of GolgiCox impregnated mPFC layer V neurons from P79 FLX and VEH brains. Areas in black indicate quantified
basilar dendrites and soma. Scale bar is 50 µm. (c) P79 FLX-exposed layer V neurons failed to reach the same
extent of basilar dendritic branching as VEH-exposed neurons. (n = 10 neurons averaged from 5 VEH mice and
n = 10 neurons averaged from 5 FLX mice). (d-e) Number of basilar branching nodes and dendritic segments
per basilar dendritic branch order were non-significantly reduced in FLX-exposed neurons compared to
VEH-exposed neurons at P79. (f-g) FLX exposure failed to impact basilar dendritic length per branch order or
number of intersections per 10 µm distance from the soma in P79 mPFC neurons. (h) Spine density per basilar
dendritic branch order was non-significantly reduced at P79. Data are means ± SEM.
across branch orders were unchanged in FLX-exposed neurons (Table 3; Fig. 3f). Comparable intersections were
observed with Sholl analysis, suggesting that spatially these dendritic arbors are similar despite altered branching
hierarchies (Fig. 3g). Finally, the spine density in FLX-exposed basilar dendrites was reduced, although this
differences did not reach statistical significance on spine densities across branch orders. An overall reduction in
spine density was observed (Fig. 3h).
To determine if the abnormalities present in the adult mPFC neurons were apparent at early postnatal ages,
we also examined mPFC layer V pyramidal neurons from P10 mice exposed to either FLX or VEH during
neurodevelopment (Fig. 3a, 4a; Tables 2 and 3). mPFC neurons at this age were largely unaffected by FLX
exposure. The soma size again was unchanged in FLX-exposed neurons (Table 3) and a similar level of branching
order was achieved in both FLX- and VEH-exposed neurons (Fig. 4b. However, an increase in nodes on 1st order
branches was observed in FLX-exposed neurons (Fig. 4c), which was accompanied by an increase in 1st and 2nd
order branching segments (Fig. 4d). This was paralleled spatially by an increase in intersections at a 20–40 µm
distance from the soma (Fig. 4e). Dendritic length was unaffected (Fig. 4f). Finally, a non-significant increase
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Figure 4.  Dendritic features of mPFC layer V pyramidal neurons are increased at P10 by Maternal FLX. (a)
Representative tracings of Golgi-Cox impregnated mPFC layer V neurons from P10 FLX and VEH brains. Areas
in black indicate quantified basilar dendrites and soma. Scale bar is 50 µm. (b) Comparable branching orders
were achieved by FLX- and VEH-exposed mPFC layer V neurons at P10 (n = 10 neurons averaged from 5 VEH
mice and n = 10 neurons averaged from 5 FLX mice). (c) First order branching nodes were increased in FLXexposed brains. (d) The number of basilar dendritic segments per branch order were increased in FLX-exposed
neurons at the 1st and 2nd orders. (e) FLX-exposed neurons showed an increased in intersections 20–40 µm
distance from the soma as assessed by Sholl analysis. (f-g) No difference was observed for basilar dendritic
length or spine density between P10 FLX- and VEH-exposed neurons. Data are means ± SEM. Statistical
significance, ***p < .001, **p < .01, *p < .05.
in spine density was also observed (Fig. 4g). These data suggest the impact of FLX on mPFC layer V neurons
during early postnatal ages is much smaller, and in the opposite direction, than that observed in adult neurons.

Discussion

Here we tested the hypothesis that early perturbation of the 5HT system disrupts neuronal architecture in areas
involved in social behavior circuitry. Using maternal SSRI exposure as a model of early 5HT system perturbation,
we observed morphological changes to layer V pyramidal neurons in areas related to social behavior deficits in
the offspring. Specifically, maternal FLX resulted in less elaborate basilar dendritic branching in M1 neurons as
well as reduced spine density during development, possibly due to enhanced dendritic pruning, which persisted
into adulthood. We observed a similar blunting of basilar dendritic branching and spine density in mPFC neurons
in adulthood, which was not present during development. Together, our morphological data indicate that 5HT
perturbation during neurodevelopment through maternal FLX exposure affects dendritic spine formation and
arborization in brain regions implicated in social behavior.
An important consideration for interpretation of our results is the degree of FLX transfer via placenta or
lactation from the dam to the offspring CNS and whether FLX may be directly acting on the offspring 5HT
system. In our previous study, we confirmed FLX reached the developing brain of the offspring via HPLC
measurement of FLX and its active metabolite NFLX in whole brains of P9 pups exposed to maternal FLX19. We
detected the presence of both FLX and NFLX in the brains of FLX-exposed pups and failed to detect either in the
VEH-exposed control brains. The levels of FLX and NFLX in the pup brains were 43% and 32%, respectively, of
that measured in an equal amount of dam brain tissue. These data indicate that FLX and NFLX were active in the
offspring brain during maternal exposure, suggesting the developing 5HT system is directly targeted, and this
activation, at least in part, is responsible for the observed phenotypes. In addition, we did not find differences in
pregnancy outcomes between our dams exposed to FLX and those exposed to VEH. This further supports that
the dendritic morphological changes resulted from direct action of FLX in the brains of the developing offspring
and not as a result of indirect action on the health of the dam during pregnancy.
Our findings complement and extend the current work in this area. Previously, the morphology of M1 layer
V pyramidal neurons were examined in rats at P35 following a short exposure duration to FLX during the first
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4 days postnatal. Similar to our findings, a decrease in complexity was reported including decreased intersections
in the Sholl analysis, dendritic order segments, nodes and endings, and total dendritic l ength22. However, to our
knowledge, no previous work has examined persistent versus transient effects of FLX on dendrites in this area.
Yet these findings at P35 together with ours at P10 and P79 in mice support the conclusion that altered 5HT
activity during development due to FLX persistently disrupts the morphology of M1 layer V pyramidal neurons.
In other studies of FLX exposure and morphological changes to the mPFC, results were counter to ours. Ko et al.,
published changes to dendritic morphology of layer II/III neurons of the mPFC with neonatal rat exposure23.
Specifically, they report increased nodes, intersections, endings, and segment number. The contrast with our
findings may stem from the difference in cortical layer or species. In addition, it is unclear from their report the
age at assessment. Thus, if these rats were assessed early in development, it is plausible we observed a similar,
albeit much reduced, effect in P10 mice. Previous work also highlighted other areas of the brain vulnerable to
FLX-induced dendritic changes. These areas include the basolateral amygdala, the layer IV barrel cortex and other
areas of the somatosensory cortex22,24. The sensory and social behavioral consequences of 5HT perturbation of
these areas is an important future research endeavor.
Work from other groups examining the impact of early manipulations to other neurotransmitter systems
on cortical neuronal morphology suggests dendritic architecture may be vulnerable to early perturbation of
any system, yet the sensitivity of this vulnerability may differ. Specifically, a model of prenatal methadone
exposure in which dams were injected with methadone daily from pre-gestation through offspring weaning
showed unchanged morphology of M1 layered V pyramidal neurons at P21-26, as measured by Sholl analysis of
intersections and length, despite altered intrinsic properties like significantly reduced firing rates and increased
amplitude of excitatory responses25. Another model of ethanol exposure from embryonic day 0-P10 exhibited
unchanged basilar intersections, larger soma area, and significantly reduced basilar spine densities of layer II/III
pyramidal neurons of the mPFC at P
 9026. Finally, a model of gestational nicotine exposure showed no change
in basilar dendritic branching, length, or spine density of layer III neurons of the anterior cingulate cortex or
mPFC at P21, yet an increase in dendritic length in layer III neurons of the parietal cortex with no accompanying
change to branching or spine density27.
Alterations in spine density have been observed across multiple studies of developmental FLX exposure,
corroborating our findings h
 ere22,23,28, suggesting this may be a particularly vulnerable feature to early 5HT
manipulations. Indeed, other pharmacological and genetic manipulations of the early 5HT system have also
shown an influence on spines. Specifically, other drugs in the SSRI class (e.g. fluvoxamine29), as well as both
the 5HT transporter k nockout30 and the 5HT synthesizing enzyme tyrosine hydroxylase 2 k nockout31 models
showed differences in spine densities.
It may be that FLX’s influence on spine formation drives the social phenotypes we previously observed.
In vitro work has shown that the 5HT1A and 5HT2A/C receptors directly inhibit and promote spine maturation,
respectively32. Work from another group demonstrated that administration of a 5HT2A antagonist prevented
the decrease in USV production induced by the SSRI paroxetine in rats33, indicating a role for this receptor in
SSRI modulation of pup USVs. Taken further, it is possible that USVs are spared by the promotion of spine
formation by 5HT2A activation counteracting a possible spine reduction by the SSRI. Further support for a
possible connection between spine density and USVs comes from work showing that the knockdown of the
human language-associated FoxP2 target SRPX2 reduced spine density and USVs in pups34. Studies of the impact
of learning on spine formation35 also indicate that such a reciprocal relationship may exist between spine density
and USVs. Future studies examining spine morphology in the presence and absence of USVs are needed to
directly examine the link between spine formation and USV production.
Previously, we also observed an increase in dominant displays of social hierarchy behavior in this m
 odel19.
The mPFC exerts top-down control on 5HT release through its projections to the dorsal raphe, specifically
inhibition36. Shifts up or down in synaptic efficacy of layer V pyramidal cells in the mPFC have been shown to
increase or decrease, respectively, social dominance rank in the m
 ouse21. What is more, 5HT has been linked to
dominance across species, although not always in the same direction. Studies in monkeys showed that higher
5HT blood or synaptic concentrations increased dominance behavior, while depletion of 5HT resulted in more
submissive behavior37. In addition, dominant monkeys had almost two times higher 5HT levels compared to
subordinate monkeys37. In contrast, feeding adult mice a tryptophan-depleted diet, and thus reducing production
of 5HT, resulted in increased dominance in the tube t est38. While the connection between 5HT and dominance
needs further investigation, it is possible that the altered mPFC morphology observed in our model influenced
dominance by impacting mPFC control of raphe 5HT activity.
Our study adds to previous morphological characterizations of developmental 5HT exposures in multiple
ways. As mentioned above, this study is the first to our knowledge to examine the effect of 5HT manipulations
at an early and late age, allowing for discussion of transient versus persistent effects on dendritic morphology.
Indeed, the amount of changes over time was quite marked, particularly in the mPFC. In addition, the duration
of our SSRI exposure protocol encompasses the periods of gestation and lactation, covering a large period
of offspring neurodevelopment. Thus, our 5HT perturbation model likely influences a broader range of
neurodevelopmental processes compared to shorter exposure durations used in the previous s tudies22–24,28,39–41.
Additionally, our route of drug administration was optimized so that the dam would experience little to no stress.
Our oral administation of FLX through drinking water avoids the daily handling and injection stress present
with intraperitoneal or subcutaneous injections42, and our pair-housing of the dams avoided any isolationinduced stress. Thus, we avoid the confound of maternal stress effects in the interpretation of our results. These
advantages of our approach may explain why our results differ somewhat from the rat layer 2/3 results described
above. A limitation of our study is the conflation of drug with litter effects, which is inherent in the design of
maternal exposure studies as within-litter controls are not possible. In addition, several of our effects were too
small to cross the statistical threshold of the 5% critical alpha level at the current power. For example, in adults
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there were differences in branch nodes and segments that echoed what had been seen in younger animals. While
not significant (p < 0.056–0.08) in adults, such a marginal p-value could still be consistent with a persistent, but
underpowered, phenotype. However, an alternative interpretation for these marginal effects is that the reduced
basilar branching complexity is begining to resolve in adulthood. Likewise FLX exposure showed interesting
adult-only trends on soma size and spine density in adult PFC that were not present in pups. For both sets of
findings, additional work is require to tease apart these interpretations.
Overall, our results indicate that M1 and mPFC are vulnerable areas to changes in 5HT activity during
neurodevelopment, at least at the cellular level. Whether these cellular changes underlie the behavioral deficits
previously reported is u
 nknown19. However, future work coupling area-specific early 5HT perturbation or GPCR
activation using neuronal signal-transduction manipulations such as Designer Receptors Exclusively Activated
by Designer Drugs (DREADDs)43 with social and sensory behavior assessments will help to further understand
the level of vulnerability of these areas to perturbed signaling during development. Ultimately, this research will
help us understand best practices when it comes to pharmacotherapies and the developing brain.

Materials and methods

Animals. All animal procedures were approved and performed in accordance with the Washington
University in St. Louis Institutional Animal Care and Use Committee. The study is reported in accordance
with ARRIVE guidelines ([https://arriveguidelines.org). We used C57BL/6J mice (https://www.jax.org/strain/
000664; RRID: IMSR_JAX:000664) for this study. A total of 22 mice (8 females and 14 males) from 7 litters (4
FLX, 3 vehicle) were used for dendritic morphology experiments. The mice were housed in 28.5 × 17.5 × 12 cm
translucent plastic cages with corn-cob bedding and standard lab diet and freely available water. The colony
room lighting was a 12/12 h light/dark cycle with room temperature (~ 20–22 °C) and relative humidity (50%)
automatically controlled. All mice participating in this study were bred and maintained in the vivarium at
Washington University in St. Louis and were all group housed by sex after P21.
Maternal SSRI administration. The SSRI administration protocol used here is the same as previously

 ublished18,19. The longer half-life of FLX, compared to other SSRIs, was ideal for this study because it allowed
p
for safe abrupt cessation of drug exposure. Dams were exposed to FLX beginning from one week prior to
mating through offspring age P14, just before pups begin to consume food and water in order to avoid direct
drug exposure in the pups. FLX was delivered through drinking water sweetened with 1% saccharin at a dose
equivalent to the maximum recommended human dose in mice which is 48 mg/d (16 mg/kg/d based on a
30-g mouse)44. The dose calculations are based on equivalent surface area dosage conversion factors45 and
approximate drinking water consumed d
 aily46. This administration route was chosen to minimize stress that can
occur with daily injections. Control dams were given 1% saccharin drinking water vehicle (VEH) only. Females
of the same treatment group were co-housed to reduce stress induced by isolation housing.

Golgi‑Cox impregnation and morphological analysis. The Golgi-Cox method22 was used to quantify

dendritic morphology. This technique, while almost 150 years old, remains a standard histological technique for
its ability to stain neurons in their entirety, including cell bodies, axons, dendritic processes, and synaptic spines.
Importantly, Golgi-Cox stains approximately 1–2% of neurons present, resulting in clearly distinguishable
neurons and processes, allowing for stereological tracing of the dendritic arbors of single n
 eurons47.

Tissue preparation. Offspring from FLX or VEH dams were deeply anesthetized using isoflurane and then
euthanized via decapitation at either P10, a developmental age at which we previously observed USV deficits, or
P79, an age at which increased social dominance behaviors were o
 bserved19. Brains were rapidly dissected and
stained via Golgi-Cox impregnation using the FD Rapid GolgiStain kit (FD NeuroTechnologies, INC, Ellicott
City, MD). All procedures followed the manufacturer’s manual with minor deviations as reported below. Freshly
dissected brains were rinsed with Milli-Q water and immersed in impregnation solution (equal parts A solution
and B solution) mixed 24 h earlier and stored in the dark. Impregnation solution was replaced with fresh solution
after the first 6 h. Incubation lasted 21 days for P10 brains and 7 days for P79 brains, with continuous agitation.
Brains were transferred to Solution C for 72 h, followed by flash freezing via immersion into −70 °C isopentane,
and stored at −80 °C until sectioning. Tissue was coronally sectioned at 200 µm using a Leica CM1950 cryostat
and immediately mounted on gelatin-coated slides using a small drop of Solution C. Within 72 h, slide-mounted
sections were stained as outlined in the manufacturer’s manual. Slides were rinsed 2 times for 4 min each in
Milli-Q water, then placed in 1:1:2 mixture Solution D: Solution E: Milli-Q water for 10 min. Sections were again
rinsed 2 times for 4 min each in Milli-Q water, followed by dehydration in 50%, 70% and 95% ethanol for 4 min
each and then 100% ethanol 4 times for 4 min each. Sections were cleared in Citrasolv and coverslipped using
Permount and allowed to dry for two weeks in the dark at 4 °C before microscopy.
Neuron selection, morphological quantification. For each region, age, and drug condition, at least 10 layer V
pyramidal neurons were randomly selected for quantitative analysis of dendritic branching and spine densities.
The selected neurons had basilar dendritic arbors that were fully impregnated with stain and were not truncated
from slicing. The apical dendrite tracings were often truncated; therefore, only morphological features of the
basilar dendrites were quantified. Each neuron had several spiny basilar dendrites extending from the cell body
and a single apical dendrite (Figs. 1c, 2a, 3b, 4a). The selection area of the primary motor cortex (M1) was based
on the location active during USV, as described by Arriaga et al.20 (between −0.02 mm and + 0.40 mm from
bregma; Fig. 1b). At this coronal level, the anterior commissure bridges the hemispheres at + 0.13 mm48, therefore
neurons were traced that occur in the section where the anterior commissure bridges ± one section anterior or
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posterior, where the limbs of the anterior commissure are well-defined but do not bridge the hemispheres. The
sampled area of the medial prefrontal cortex (mPFC) (about + 1.94 mm from bregma; Fig. 3a) was motivated by
studies of Wang et al.21, showing that the synaptic efficacy of neurons in this area mediated social dominance.
This region of mPFC is posterior to the olfactory bulb, anterior to the basal g anglia48, and corresponded to the
anterior cingulate cortex, prelimbic area and infralimbic area21.
All neurons were manually traced using a 60 × oil objective on a Nikon E800 Eclipse microscope and Microfire
A/R camera by Optronics with a Nikon Optem 1X DC10NN adapter connected to a Dell Precision T3600
computer equipped with Neurolucida software (MBF Bioscience, Williston, VT). Based on our previously
published methods, tracing involved drawing the maximum contour of the soma, following all dendrites along
their entire length, and marking all visible dendritic spines49. Neuronal morphology was quantified according
to eight measures adapted from Bianchi et al.49 including number of dendritic spines, total dendritic length,
dendritic spine density (ratio of spines per 1 µm dendritic length), number of branching segments, number of
branching nodes, number of branching segment endings, total dendritic field area (total area encompassed by
the branched structure; µm2), soma area (µm2), and highest branching order. Branch order is defined by level
removed from soma, such that the dendritic branches originating from the soma are considered first-order
branch segments, and branches originating from first-order are second-order segments, and so on. As most apical
dendrites passed out of the plane of sectioning, only basilar dendrites were included in quantitative analyses. In
addition to these measures a Sholl analysis was performed, which assessed neuronal complexity as it spatially
relates to the soma. In short, the Sholl analysis involved placing concentric circles with gradually increasing radii
centered at the centroid of the soma. For each neuron, we tracked the number of times dendrites intersect with
a circle of a given radius.
All tracings were obtained by two researchers (C.J. and S.A.), who were normed to an experienced rater
(A.L.B.)49 and checked by the primary investigator (S.E.M.). All assessments were conducted blinded for
treatment group. As assessed by the coefficient of intraclass correlation, interrater reliability was high in all
measures of interest (C.J. vs. S.A.): dendritic spines = 0.817; dendritic length = 0.968; branching nodes = 0.885;
branch segment endings = 0.956; and soma area = 0.805.

Statistical analysis. All statistical analyses were performed using the IBM SPSS Statistic software (v.28).
Prior to analyses, all data was screened for missing values, fit between distributions and the assumptions of
univariate analysis, and homogeneity of variance. Averages were calculated for each outcome across individual
neurons traced within each brain (one to four per mouse) and data analyzed at the level of mouse. Twotailed analysis of variance (ANOVA), including one-way and repeated measures ANOVA, were used where
appropriate. Pooled error variances were used when assessing simple main effects of drug across each level
of repeated measures. The Huynh–Feldt adjustment was used to protect against violations of sphericity/
compound symmetry assumptions where appropriate. Non-parametric testing (e.g. Mann–Whitney U) was
used for comparing distributions that violated assumptions of univariate parametric analysis. Multiple pairwise
comparisons were subjected to Bonferroni correction when appropriate. Critical alpha value for all analyses was
p < 0.05. Test statistics are provided in Table 2.

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding
author upon reasonable request.
Received: 30 September 2021; Accepted: 12 April 2022

References

1. Lin, S.-H., Lee, L.-T. & Yang, Y. K. Serotonin and mental disorders: A concise review on molecular neuroimaging evidence. Clin.
Psychopharmacol. Neurosci. 12, 196–202 (2014).
2. Gorman, J. M. & Kent, J. M. SSRIs and SNRIs: Broad spectrum of efficacy beyond major depression. J. Clin. Psychiatry 60, 33–39
(1999).
3. Soorya, L., Kiarashi, J. & Hollander, E. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.
Child Adolesc. Psychiatr. Clin. N. Am. 17, 753–771 (2008).
4. Murphy, S. E. et al. The knowns and unknowns of SSRI treatment in young people with depression and anxiety: Efficacy, predictors,
and mechanisms of action. Lancet Psychiatry 8, 824–835 (2021).
5. Sodhi, M. S. & Sanders-Bush, E. Serotonin and brain development. Int. Rev. Neurobiol. 59, 111–174 (2004).
6. Whitaker-Azmitia, P. M. CHAPTER 3.1 - Serotonin and Development*. In Handbook of Behavioral Neuroscience (ed. Jacobs, C.
P. M. and B. L.) vol. 21, 309–323 (Elsevier, 2010).
7. Whitaker-Azmitia, P. M., Druse, M., Walker, P. & Lauder, J. M. Serotonin as a developmental signal. Behav. Brain Res. 73, 19–29
(1996).
8. Muller, C. L. et al. Impact of maternal serotonin transporter genotype on placental serotonin, fetal forebrain serotonin, and
neurodevelopment. Neuropsychopharmacology https://doi.org/10.1038/npp.2016.166 (2016).
9. Goeden, N. et al. Maternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal
brain. J. Neurosci. 36, 6041–6049 (2016).
10. Smythies, J. Section V. Serotonin System. in (ed. Neurobiology, B.-I. R. of) vol. 64 217–268 (Academic Press, 2005).
11. Lucki, I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 44, 151–162 (1998).
12. Dölen, G., Darvishzadeh, A., Huang, K. W. & Malenka, R. C. Social reward requires coordinated activity of nucleus accumbens
oxytocin and serotonin. Nature 501, 179–184 (2013).
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. (American Psychiatric Association
Publishing, 2013).
14. Derntl, B. & Habel, U. Deficits in social cognition: A marker for psychiatric disorders?. Eur. Arch. Psychiatry Clin. Neurosci.
261(Suppl 2), S145-149 (2011).

Scientific Reports |
Vol:.(1234567890)

(2022) 12:7605 |

https://doi.org/10.1038/s41598-022-11614-w

10

www.nature.com/scientificreports/
15. Hoertnagl, C. M. & Hofer, A. Social cognition in serious mental illness. Curr. Opin. Psychiatry 27, 197–202 (2014).
16. Kennedy, D. P. & Adolphs, R. The social brain in psychiatric and neurological disorders. Trends Cogn. Sci. 16, 559–572 (2012).
17. Kiser, D., SteemerS, B., Branchi, I. & Homberg, J. R. The reciprocal interaction between serotonin and social behaviour. Neurosci.
Biobehav. Rev. 36, 786–798 (2012).
18. Rahn, R. M., Maloney, S. E., Brier, L. M., Dougherty, J. D. & Culver, J. P. Maternal fluoxetine exposure alters cortical hemodynamic
and calcium response of offspring to somatosensory stimuli. eNeuro https://doi.org/10.1523/ENEURO.0238-19.2019 (2019).
19. Maloney, S. E. et al. Examining the reversibility of long-term behavioral disruptions in progeny of maternal SSRI exposure. eNeuro
5, ENEURO.0120-18.2018. https://doi.org/10.1523/ENEURO.0120-18.2018 (2018).
20. Arriaga, G., Zhou, E. P. & Jarvis, E. D. Of mice, birds, and men: The mouse ultrasonic song system has some features similar to
humans and song-learning birds. PLoS ONE 7, e46610 (2012).
21. Wang, F. et al. Bidirectional control of social hierarchy by synaptic efficacy in medial prefrontal cortex. Science 334, 693–697 (2011).
22. Lee, L.-J. & Lee, L.J.-H. Neonatal fluoxetine exposure alters motor performances of adolescent rats. Dev. Neurobiol. 72, 1122–1132
(2012).
23. Ko, M.-C., Lee, L.J.-H., Li, Y. & Lee, L.-J. Long-term consequences of neonatal fluoxetine exposure in adult rats: Early SSRI Affects
Limbic System. Dev. Neurobiol. 74, 1038–1051 (2014).
24. Song, T. et al. Repeated fluoxetine treatment induces long-lasting neurotrophic changes in the medial prefrontal cortex of adult
rats. Behav. Brain Res. 365, 114–124 (2019).
25. Grecco, G. G. et al. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties
and local circuitry. Elife 10, e66230 (2021).
26. Lawrence, R. C., Otero, N. K. H. & Kelly, S. J. Selective effects of perinatal ethanol exposure in medial prefrontal cortex and nucleus
accumbens. Neurotoxicol. Teratol. 34, 128–135 (2012).
27. Muhammad, A. et al. Prenatal nicotine exposure alters neuroanatomical organization of the developing brain. Synapse 66, 950–954
(2012).
28. Lee, L.-J. Neonatal fluoxetine exposure affects the neuronal structure in the somatosensory cortex and somatosensory-related
behaviors in adolescent rats. Neurotox. Res. 15, 212–223 (2009).
29. Zheng, J. et al. Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal
neurons. Int. J. Clin. Exp. Pathol. 4, 162–168 (2011).
30. Wellman, C. L. et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter
knock-out mice. J. Neurosci. 27, 684–691 (2007).
31. Maddaloni, G. et al. Serotonin depletion causes valproate-responsive manic-like condition and increased hippocampal
neuroplasticity that are reversed by stress. Sci. Rep. 8, 11847 (2018).
32. Yoshida, H. et al. Subtype specific roles of serotonin receptors in the spine formation of cortical neurons in vitro. Neurosci. Res.
71, 311–314 (2011).
33. Schreiber, R., Melon, C. & De Vry, J. The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake
inhibitors in the rat ultrasonic vocalization test. Psychopharmacology 135, 383–391 (1998).
34. Sia, G. M., Clem, R. L. & Huganir, R. L. The human language-associated gene SRPX2 regulates synapse formation and vocalization
in mice. Science https://doi.org/10.1126/science.1245079 (2013).
35. Moser, M. B., Trommald, M. & Andersen, P. An increase in dendritic spine density on hippocampal CA1 pyramidal cells following
spatial learning in adult rats suggests the formation of new synapses. Proc. Natl. Acad. Sci. 91, 12673–12675 (1994).
36. Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G. & Artigas, F. Control of dorsal raphe serotonergic neurons by the medial
prefrontal cortex: Involvement of serotonin-1A, GABAA, and glutamate receptors. J. Neurosci. 21, 9917–9929 (2001).
37. Watanabe, N. & Yamamoto, M. Neural mechanisms of social dominance. Front. Neurosci. 9, 154 (2015).
38. Uchida, S. et al. Chronic reduction in dietary tryptophan leads to changes in the emotional response to stress in mice. J. Nutr. Sci.
Vitaminol. 51, 175–181 (2005).
39. Chen, F. et al. Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat hippocampus. Eur.
Neuropsychopharmacol. 26, 234–245 (2016).
40. Ampuero, E. et al. Chronic fluoxetine treatment induces maturation-compatible changes in the dendritic arbor and in synaptic
responses in the auditory cortex. Front. Pharmacol. 10, 804 (2019).
41. Rebello, T. J. et al. Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. J. Neurosci. 34,
12379–12393 (2014).
42. Matrisciano, F. et al. Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype
induced by prenatal stress in mice. Neuropharmacology 68, 184–194 (2013).
43. Roth, B. L. DREADDs for neuroscientists. Neuron 89, 683–694 (2016).
44. Marken, P. A. & Munro, J. S. Selecting a selective serotonin reuptake inhibitor: Clinically important distinguishing features. Prim.
Care Companion J Clin Psychiatry 2, 205–210 (2000).
45. Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H. & Skipper, H. E. Quantitative comparison of toxicity of anticancer agents
in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50, 219–244 (1966).
46. Bachmanov, A. A., Reed, D. R., Beauchamp, G. K. & Tordoff, M. G. Food intake, water intake, and drinking spout side preference
of 28 mouse strains. Behav. Genet. 32, 435–443 (2002).
47. Das, G., Reuhl, K. & Zhou, R. The Golgi-Cox method. Methods Mol. Biol. 1018, 313–321 (2013).
48. Franklin, K. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates (Academic Press, 2008).
49. Bianchi, S. et al. Neocortical neuron morphology in Afrotheria: Comparing the rock hyrax with the African elephant. Ann. N. Y.
Acad. Sci. 1225, 37–46 (2011).

Acknowledgements

The authors would like to thank Drs. Andreas Burkhalter and Rinaldo D’Souza for generous access to equipment
and training.

Author contributions

S.E.M. and J.D.D. contributed to the conception and design of the work; C.J., S.A. and A.L.B. contributed to the
acquisition of data; S.E.M. and A.L.B. contributed to the analysis and interpretation of the data. S.E.M., D.R.T.,
and A.L.B. wrote manuscript; S.E.M., D.R.T., A.L.B. and J.D.D. revised the manuscript; all authors gave final
approval of the version to be published and are accountable for all aspects of the work.

Funding

This work was funded by W.M. Keck Fellowship in Molecular Medicine from Washington University in St. Louis
(SEM), and the NIH (P50 HD103525, IDDRC@WUSTL).

Scientific Reports |

(2022) 12:7605 |

https://doi.org/10.1038/s41598-022-11614-w

11
Vol.:(0123456789)

www.nature.com/scientificreports/

Competing interests

The authors declare no competing interests.

Additional information

Correspondence and requests for materials should be addressed to S.E.M.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons licence, and indicate if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2022

Scientific Reports |
Vol:.(1234567890)

(2022) 12:7605 |

https://doi.org/10.1038/s41598-022-11614-w

12

